Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Nakayama

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Cancer Research|September 7, 2007
NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressorKentaro Nakayama, Naomi Nakayama, Tian-Li Wang, et al.
International Journal of Clinical Oncology|December 8, 2009
A case of bilateral pelvic lymph node involvement in stage 1a1 squamous cell carcinoma of cervix and a review of the literatureShamima Yeasmin, Kentaro Nakayama, Masako Ishikawa, et al.
International Journal of Clinical Oncology|April 27, 2010
Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancerKentaro Nakayama, Yutaka Nagai, Masako Ishikawa, et al.
Diagnostics (Basel, Switzerland)|December 5, 2019
Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer PatientsNaomi Nakayama, Kentaro Nakayama, Kohei Nakamura, et al.
International Journal of Molecular Sciences|October 16, 2025
NAC1 Regulates PCK2 Expression and Activates Truncated Gluconeogenesis for Growth Advantage in Ovarian Cancer CellsNaomi Nakayama, Kentaro Nakayama, Puja Dey, et al.
Gynecologic Oncology|March 30, 2004
Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancerKohkichi Hata, Kentaro Nakayama, Ritsuto Fujiwaki, et al.
Molecular and Clinical Oncology|March 31, 2017
High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case reportEmi Sato, Kentaro Nakayama, Masako Ishikawa, et al.
BMC Women'S Health|March 19, 2015
A case with life-threatening uterine bleeding due to postmenopausal uterine arteriovenous malformationEmi Sato, Kentaro Nakayama, Kohei Nakamura, et al.
International Journal of Cancer|September 7, 2002
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRPKentaro Nakayama, Atsuko Kanzaki, Kenji Ogawa, et al.
International Journal of Clinical Oncology|March 11, 2010
Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetateKentaro Nakayama, Masako Ishikawa, Yutaka Nagai, et al.
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Cancer Research|September 7, 2007
NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressorKentaro Nakayama, Naomi Nakayama, Tian-Li Wang, et al.
International Journal of Clinical Oncology|December 8, 2009
A case of bilateral pelvic lymph node involvement in stage 1a1 squamous cell carcinoma of cervix and a review of the literatureShamima Yeasmin, Kentaro Nakayama, Masako Ishikawa, et al.
International Journal of Clinical Oncology|April 27, 2010
Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancerKentaro Nakayama, Yutaka Nagai, Masako Ishikawa, et al.
Diagnostics (Basel, Switzerland)|December 5, 2019
Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer PatientsNaomi Nakayama, Kentaro Nakayama, Kohei Nakamura, et al.
International Journal of Molecular Sciences|October 16, 2025
NAC1 Regulates PCK2 Expression and Activates Truncated Gluconeogenesis for Growth Advantage in Ovarian Cancer CellsNaomi Nakayama, Kentaro Nakayama, Puja Dey, et al.
Gynecologic Oncology|March 30, 2004
Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancerKohkichi Hata, Kentaro Nakayama, Ritsuto Fujiwaki, et al.
Molecular and Clinical Oncology|March 31, 2017
High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case reportEmi Sato, Kentaro Nakayama, Masako Ishikawa, et al.
BMC Women'S Health|March 19, 2015
A case with life-threatening uterine bleeding due to postmenopausal uterine arteriovenous malformationEmi Sato, Kentaro Nakayama, Kohei Nakamura, et al.
International Journal of Cancer|September 7, 2002
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRPKentaro Nakayama, Atsuko Kanzaki, Kenji Ogawa, et al.
International Journal of Clinical Oncology|March 11, 2010
Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetateKentaro Nakayama, Masako Ishikawa, Yutaka Nagai, et al.
Pageof 18